Search Results - "Bleeker, Jonathan"

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update by Loprinzi, Charles L, Lacchetti, Christina, Bleeker, Jonathan, Cavaletti, Guido, Chauhan, Cynthia, Hertz, Daniel L, Kelley, Mark R, Lavino, Antoinette, Lustberg, Maryam B, Paice, Judith A, Schneider, Bryan P, Lavoie Smith, Ellen M, Smith, Mary Lou, Smith, Thomas J, Wagner-Johnston, Nina, Hershman, Dawn L

“…To update the ASCO guideline on the recommended prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathy (CIPN) in…”
Get full text

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline by HERSHMAN, Dawn L, LACCHETTI, Christina, PAICE, Judith, SCHNEIDER, Bryan, SMITH, Mary Lou, SMITH, Tom, TERSTRIEP, Shelby, WAGNER-JOHNSTON, Nina, BAK, Kate, LOPRINZI, Charles L, DWORKIN, Robert H, LAVOIE SMITH, Ellen M, BLEEKER, Jonathan, CAVALETTI, Guido, CHAUHAN, Cynthia, GAVIN, Patrick, LAVINO, Antoinette, LUSTBERG, Maryam B

“…To provide evidence-based guidance on the optimum prevention and treatment approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN)…”
Get full text

Scleroderma‐like skin changes induced by checkpoint inhibitor therapy by Tjarks, B. Joel, Kerkvliet, Amy M., Jassim, Ali D., Bleeker, Jonathan S.

“…Checkpoint inhibitors have emerged as beneficial therapies in many different types of malignancy. The most common toxicities of checkpoint inhibitors are…”
Get full text

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia by Gangat, Naseema, Bleeker, Jonathan, Lynch, Douglas, Olteanu, Horatiu, Letendre, Louis, Tefferi, Ayalew

Get full text

Malignant＂ Perivascular Epithelioid Cell Neoplasm: Risk Stratification and Treatment Strategies by Bleeker, Jonathan S., Quevedo, J. Fernando, Folpe, Andrew L.

“…Purpose. Perivascular epithelioid cell tumors (PEComas) are a rare collection of tumors characterized by a myomelanocytic phenotype, and PEComas occurring in…”
Get full text

Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma by Gustafson, Michael P, Lin, Yi, Bleeker, Jonathan S, Warad, Deepti, Tollefson, Matthew K, Crispen, Paul L, Bulur, Peggy A, Harrington, Susan M, Laborde, Rebecca R, Gastineau, Dennis A, Leibovich, Bradley C, Cheville, John C, Kwon, Eugene D, Dietz, Allan B

“…Immunotherapeutic strategies to treat patients with renal cell carcinoma (RCC) offer new opportunities for disease management. Further improvements to…”
Get full text

Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab by Ellithi, Moataz, Shahid, Mahum, Abdullah, Hafez Mohammad, Bleeker, Jonathan

Get full text

Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs by Bleeker, Jonathan S., Syed, Faisal F., Cooper, Leslie T., Weiler, Catherine R., Tefferi, Ayalew, Pardanani, Animesh

Get full text

Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program by Bleeker, Jonathan S., Sumey, Christopher J., Powell, Steven F., Steen, Preston D., Keppen, Michael D., Lohr, Michele, Thambi-Pillai, Thavam, Kurniali, Peter, Mazurczak, Miroslaw, Gitau, Mark M., Blanchard, Miran J., Nowak, Ryan K., McGraw, Steven, Sticca, Robert, Tuvin, Daniel, Timmerman, Gary

“…Treatment paradigms for borderline resectable pancreatic cancer are evolving with increasing use of neoadjuvant chemotherapy and neoadjuvant chemoradiation…”
Get full text

EBV-Associated Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis in a Patient with Severe Celiac Disease by Lamfers, Randall, Pownell, Brandy, Chakravarthy Potu, Kalyan, Kinross-Wright, John Jacob, Bleeker, Jonathan S.

“…Background. Epstein-Barr virus- (EBV-) associated lymphoproliferative disease (LPD) is a rare condition, usually occurring in immunocompromised patients. We…”
Get full text

Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis by Desai, Chirag K., Hayes, Sharonne N., Shah, Mithun Vinod, Maleszewski, Joseph J., Bleeker, Jonathan, Steffen, Kelly, Stys, Maria

“…Rosai-Dorfman disease is a rare, idiopathic disorder of histiocyte proliferation. We describe a case of a 59-year-old woman who presented with heart failure…”
Get full text

Evaluation of pretransplant factors predicting cardiac dysfunction following high-dose melphalan conditioning and autologous peripheral blood stem cell transplantation by Bleeker, Jonathan S., Gertz, Morie A., Pellikka, Patricia A., Larson, Dirk R., Buadi, Francis, Dingli, David, Dispenzieri, Angela, Hayman, Suzanne R., Hogan, William, Kumar, Shaji, Rajkumar, S. Vincent, Lacy, Martha Q.

“…Background Cardiac complications following hematopoietic stem cell transplantation (HSCT) are emerging as a significant concern given the increasing…”
Get full text

Malignant perivascular epithelioid cell tumor of the uterus by Bleeker, Jonathan S, Quevedo, J Fernando, Folpe, Andrew L

“…Perivascular epithelioid cell tumors (PEComas) are a rare collection of tumors arising in a wide array of anatomic locations and characterized by a…”
Get full text

Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance Imaging by Syed, Faisal F., MBChB, Bleeker, Jonathan S., MD, Glockner, James, MD, Pardanani, Animesh, MBBS, PhD, Cooper, Leslie T., MD

“…Electrocardiography-gated cardiac magnetic resonance imaging demonstrated anterior, anterolateral, inferolateral, and inferior left ventricular (LV) wall…”
Get full text

Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies by Bleeker, Jonathan S., Hogan, William J.

“…Thrombocytosis is a commonly encountered clinical scenario, with a large proportion of cases discovered incidentally. The differential diagnosis for…”
Get full text

CYP2D6 and Tamoxifen: Lessons Learned by Lu, Wenjie Jessie, Bleeker, Jonathan S

Get more information

Oncology patient and provider preferences regarding rapid radiology result release to online portals by Bleeker, Jonathan, Wernisch, Jan, Tronier, Shawn, Terstriep, Shelby A.

“…Abstract only 1544 Background: Spurred by changes in legislation and technology, rapid patient access to medical results has never been higher. Many health…”
Get full text

Clinical outcomes of checkpoint inhibitors in metastatic non-clear cell renal cell carcinoma and clear cell renal cell carcinoma with variant features by Chang, Guy vin, Ellithi, Moataz, Elnair, Radowan, Bleeker, Jonathan

“…Abstract only e17065 Background: Checkpoint inhibitors (CPI) are a well-established treatment option for advanced clear cell renal cell carcinoma (ccRCC);…”
Get full text

Survival analysis of CLL/SLL patients with Richter’s transformation to DLBCL: An analysis of the SEER database by Elnair, Radowan, Ellithi, Moataz, Kallam, Avyakta, Bleeker, Jonathan, Bociek, Gregory

“…Abstract only e20024 Background: Richter's transformation (RT) from Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) to a Diffuse Large B-Cell…”
Get full text

Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy by Wynja, Emily, Solomon, Benjamin, Bleeker, Jonathan

“…Checkpoint inhibitor immunotherapy has recently been proven to be an attractive treatment option for a wide variety of malignancies. Nivolumab, an…”
Get full text